S
SGMO//CIK 0001001233
SANGAMO THERAPEUTICS, INC
Market Data
$0.37−$0.06 (−14.81%)
SGMO · Last trade
Prev Close
$0.43
Range (30d)
$0.37 – $0.46
Recent Filings
- 10-Q6.4 MBSANGAMO THERAPEUTICS, INCNov 6, 8:07 AM ET·0001001233-25-000024
- 8-K338.3 KBSANGAMO THERAPEUTICS, INCNov 6, 8:05 AM ET·0001001233-25-000023
- 8-K149.2 KBSANGAMO THERAPEUTICS, INCOct 29, 4:08 PM ET·0001001233-25-000015
- 8-K148.2 KBSANGAMO THERAPEUTICS, INCSep 30, 4:01 PM ET·0001001233-25-000013
- 8-K143.3 KBSANGAMO THERAPEUTICS, INCSep 11, 5:00 PM ET·0001001233-25-000011
- 8-K6.9 MBSANGAMO THERAPEUTICS, INCSep 4, 8:06 AM ET·0001001233-25-000006
- 10-Q5.6 MBSANGAMO THERAPEUTICS, INCAug 7, 4:05 PM ET·0001628280-25-038860
- 8-K328.9 KBSANGAMO THERAPEUTICS, INCAug 7, 4:02 PM ET·0001628280-25-038855
- 8-K164.5 KBSANGAMO THERAPEUTICS, INCJun 24, 8:08 AM ET·0001628280-25-032748
- 8-K724.3 KBSANGAMO THERAPEUTICS, INCJun 16, 4:06 PM ET·0001628280-25-031559
Insiders
10- ANDO DALE GVP, Therapeutic Dev. & CMO
- Beers CourtneyDirector
- BIOGEN INC.10% Owner
- BLUFORD PETERVP, Corporate Development
- Boissel StephaneEVP, Corporate Strategy
- Carey RobertDirector
- CASE CASEY CVP, Research & Operations
- Cleveland Paul BDirector
- Conner Edward R.Senior VP & CMO
- Davis Gregory DHead of Research & Technology
Tickers
Addresses
business
501 CANAL BLVD.
RICHMOND, CA, 94084
mailing
501 CANAL BLVD.
RICHMOND, CA, 94084
Former Names
- SANGAMO BIOSCIENCES INC2017-01-06